Fulcrum: Next Set Of SCD Data Is Crucial For Continued Pipeline Advancement
Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.
verywellhealth21d
What Happens When A1C Levels Are Too High?
A high hemoglobin A1C, or A1C, shows your body has difficulty regulating glucose levels. When your A1C is too high, you are at greater risk of diabetes complications such as kidney disease, ...
C&EN29d
Beyond Polymerization: In Situ Coupled Fluorination Enables More Stable Interfaces for Solid-State Lithium Batteries
Nanoyang Group, Tianjin Key Laboratory of Advanced Carbon and Electrochemical Energy Storage, School of Chemical Engineering and Technology, National Industry-Education Integration Platform of Energy ...
PipelineReview.com1mon
YolTech Therapeutics to Initiate a Clinical Trial for YOLT-204, a First-in-Class Bone Marrow-Targeted In Vivo Gene Editing Therapy for β-Thalassemia
YOLT-204 may also be an effective treatment for patients with sickle cell disease (SCD), as increased expression of fetal hemoglobin in these patients has been associated with less polymerization of ...
C&EN1mon
Emulsion Polymerization of Styrene to Polystyrene Nanoparticles with Self-Emulsifying Nanodroplets as Nucleus
Research Center for Water Resources and Interface Science, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200062, China ...
Frontiers1y
Actin polymerization and depolymerization in developing vertebrates
F-actin is formed by the polymerization of G-actin, and the dynamic balance of polymerization and depolymerization ensures proper cellular function. Disruption of this balance results in various ...
Nature24y
Nanoscale control of chain polymerization
Polymer industries depend on the spontaneous polymerization of molecules into chains in response to an appropriate trigger. We have succeeded in inducing and guiding chain polymerization over tiny ...